K E Y W O R D S
10-hydroxy-2-decenoic acid, Akt, AMP-activated protein kinase (AMPK), aquaporin 9 (AQP9), forkhead box a2 (Foxa2), insulin function as an energy sensor in the maintenance of the homeostasis of glyco-and lipid metabolism (Kahn, Alquier, Carling, & Hardie, 2005) . The activation of AMPK by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside (AICAR) was previously shown to suppress AQP9 expression via the phosphorylation of Akt followed by the phosphorylation and nuclear exclusion of Foxa2 (Yokoyama et al., 2011) .
10-Hydroxy-trans-2-decenoic acid (10H2DA), 3,10-dihydroxydecanoic acid, and sebacic acid are unique medium chain fatty acids in royal jelly (Lercker, Capella, Conte, Ruini, & Giordani, 1981) . 10H2DA has been reported to exhibit various pharmacological activities such as antitumor (Townsend et al., 1960) , antibiotic (Blum, Novak, & Taber, 1959) , neuron proliferator (Hattori, Nomoto, Fukumitsu, Mishima, & Furukawa, 2007) , immunomodulator , and anti-rheumatic effects (Yang et al., 2010) . Some of the mechanisms by which 10H2DA exerts these effects were recently elucidated. For example, 10H2DA inhibited the LPS-induced activation via specific reductions in LPS-induced IκB-ζ expression and also suppressed LPS-induced IL-6 production in murine macrophage-derived RAW264 cells . 10H2DA suppressed the mRNA expression of matrix metalloproteinases by blocking p38 kinase and c-Jun Nterminal kinase-activator protein-1 signaling pathways in rheumatoid arthritis synovial fibroblasts (Wang et al., 2012) . It has also been shown to modulate the recruitment of estrogen receptors α and β, and β only to the pS2 promoter in the presence and absence of estradiol, respectively, in MCF-7 cells (Moutsatsou et al., 2010) .
Previous studies reported that royal jelly exhibited insulin-like activity as a hypoglycemic effect (Münstedt, Bargello, & Hauenschild, 2009; Nomura et al., 2007; Zamami et al., 2008) . Kameda, Chikaki, Morimoto, Jiang, and Okuda (1996) demonstrated that 10H2DA inhibited lipolysis, stimulated lipogenesis, and exerted insulin-like effects. Thus, 10H2DA is a candidate component in royal jelly for its hypoglycemic effects. We initially investigated whether 10H2DA affected AQP9 mRNA expression because AQP9 is permeable to glycerol in the liver and glycerol is a source material for glyco-and lipid metabolism. The results obtained showed that 10H2DA suppressed AQP9 mRNA expression. We herein elucidated the mechanisms by which 10H2DA inhibits AQP9 mRNA expression.
| MATERIAL S AND ME THODS

| Materials
10H2DA was purchased from Alfresa Pharma, and royal jelly was 
| Cell culture and treatment with 10H2DA
HepG2 cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 µg/ml streptomycin, and 100 units/ml penicillin. Cells were plated on a 24-well culture plate at a density of 2 × 10 5 cells/well and incubated in a CO 2 incubator for 24 hr. Cells were washed once with phosphate-buffered saline (PBS) and then treated with 10H2DA.
10H2DA was neutralized with 0.1 M NaOH before being added to the culture medium.
| Real-time reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from HepG2 cells with TRIzol reagent.
First-strand cDNA was prepared from 5 µg total RNA with the 
| Western blot analysis
HepG2 cells treated with or without 10H2DA were lysed with lysis buffer consisting of 20 mM Tris/HCl, pH 7.5, 250 mM sodium chloride, 1 mM EDTA, 1 mM EGTA, 1% (w/v) Triton X-100, 10% (w/v) glycerol, 1 mM dithiothreitol, 0.2 mM PMSF, 0.5 µg/ml leupeptin, 1 µg/ml pepstatin, 2 mM sodium orthovanadate, 2 mM β-glycerophosphate, and 5 mM sodium fluoride. Protein concentrations in lysates were measured using the Bradford assay with BSA as a standard and Bio-Rad protein assay reagent. Twenty micrograms of protein were boiled for 5 min with 1% sodium dodecyl sulfate (SDS) and 4 mM 2-mercaptoethanol and then loaded onto a 12% SDS-polyacrylamide gel. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was then conducted according to the method of Laemmli (1970) . Western blotting was performed by the method of Towbin, Staehelin, and Gordon (1979) . After proteins in the gel had been electroblotted onto an Immobilon membrane, the desired protein was probed with the specific primary antibody followed by the peroxidase-conjugated secondary antibody. Peroxidase activity was detected with an Amersham ECL Plus Western blotting detection system according to the manufacturer's instructions using LAS-3000 UV mini (Fujifilm Corp.).
| Statistical analysis
The significance of differences between two groups and multiple groups was assessed using Student's t test and a one-way analysis of variance followed by Dunnett's test, respectively.
| RE SULTS
| Effects of 10H2DA on AQP9 mRNA expression
We examined whether 10H2DA and royal jelly affected AQP9 mRNA 
| Phosphorylation of AMPK and Akt by 10H2DA
We previously reported that 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), an AMP-activated protein kinase (AMPK) activator, induced the phosphorylation of AMPK and Akt, and down-regulated AQP9 gene expression in HepG2 cells (Yokoyama et al., 2011) . Since AQP9 gene expression was down-regulated by the treatment with 10H2DA, we investigated F I G U R E 1 Suppression of AQP9 gene expression by royal jelly and 10-hydroxy-2-decenoic acid (10H2DA). HepG2 cells were incubated with various concentrations of (a) royal jelly and (b) 10H2DA for 24 hr and (c) 4 mM 10H2DA for the period indicated. Cells incubated without royal jelly and 10H2DA were used as a control. AQP9 mRNA expression was quantified by real-time RT-PCR after total RNA was extracted, and first-strand cDNAs were synthesized. Results were normalized with β2-microglobulin mRNA levels, and the mRNA level of the control was taken as 100%. Data show the mean ± SD of five experiments. inhibitor, Y27632, palmostatin B, wortmannin, and LY294002 for Rac1, and Rho-associated coiled-coil forming kinase (ROCK), β-lactone acyl protein thioesterase 1 (APT1), and phosphoinositide 3-kinase (PI3K) were used to examine the signaling pathways related to the rat sarcoma (Ras) protein, low-molecular-weight GTPase, and G protein-coupled receptor (Figure 2c ). Y-27632 and palmostatin B partially recovered the suppression of AQP9 mRNA expression by 10H2DA, whereas the Rac1 and PI3K inhibitors had no effect. These results suggest that Rho kinase and N-Ras participate in the signaling pathway triggered by 10H2DA in HepG2 cells and also that Akt is not phosphorylated by the activation of PI3K in the pathway.
| Effects of 10H2DA on Foxa2 expression
AMPK activation (Yokoyama et al., 2011) and insulin signaling (Howell & Stoffel, 2009) (Figure 3a and b) . The suppression of Foxa2 mRNA expression by 10H2DA was observed earlier than that of AQP9 mRNA expression. Foxa2 contains a functional nuclear export signal (NES) and is excluded from the nucleus via a chromosome region maintenance (CRM) 1-dependent pathway in response to insulin signaling (Howell & Stoffel, 2009 ). Therefore, the CRM1 inhibitor, leptomycin B (LMB), was employed in the present study to suppress AQP9 mRNA expression via the regulation of Foxa2 triggered by 10H2DA (Figure 3c ). Since Foxa2 was retained in nuclei by the inhibition of CRM1 with leptomycin B, F I G U R E 2 Activation of kinases by 10H2DA. (a) HepG2 cells were incubated with 4 mM 10H2DA for the period indicated. Cell lysates were prepared with lysis buffer containing SDS and 2-mercaptoethanol, and 20 µg protein from the lysate was separated by electrophoresis with a 12% SDS-polyacrylamide gel. After proteins in the gel were electroblotted on a PVDF membrane, phosphorylated Akt (Thr-308), phosphorylated Akt (Ser-473), Akt, phosphorylated AMPKα (Thr-172), and AMPKα were probed with specific antibodies and visualized using a secondary antibody-peroxidase conjugate and the ECL system. (b) and (c) HepG2 cells were pre-incubated with various inhibitors for 1 hr and then treated with or without 10H2DA for 24 hr. Cells incubated without 10H2DA, and inhibitors were used as a control. AQP9 mRNA expression was quantified by real-time RT-PCR. Results were normalized with β2-microglobulin mRNA levels and the mRNA level of the control was taken as 100%. Data show the mean ± SD of five experiments. mRNA expression levels were similar to those of the control. However, these expression levels were lower than those without 10H2DA.
These results suggest that 10H2DA induces the nuclear exclusion of Foxa2 and suppression of Foxa2 expression. Wolfrum, Besser, Luca, and Stoffel (2003) demonstrated that insulin suppressed phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) gene expression in glycometabolism. This suppression was based on the phosphorylation and nuclear exclusion of Foxa2 in response to PI3K-Akt signaling by insulin. Since 10H2DA suppressed AQP9 mRNA expression via Foxa2, we investigated whether 10H2DA affected the gene expression of these enzymes and compared its effects to those of regulation by insulin (Figure 4 ).
| Differences from insulin
The gene expression of these enzymes, except for G6Pase, was upregulated by 4 mM 10H2DA. These results suggest that the effects of 10H2DA on glycometabolism differ from those of insulin, even though AQP9 gene expression was down-regulated by insulin and 10H2DA.
| D ISCUSS I ON
In the present study, we demonstrated that 10H2DA suppressed may have a negative impact on this supply of glycerol into the liver, indicating that 10H2DA promotes glycolysis and lipogenesis as an insulin-like effect (Kameda et al., 1996) . However, 10H2DA exerted different effects on PEPCK and G6Pase gene expression to those of insulin (Figure 4 ) even though previous findings showed that the insulin-induced gene expression of AQP9 (Yokoyama et al., 2011) and these enzymes (Wolfrum et al., 2003) was regulated by Foxa2.
Therefore, 10H2DA does not appear to exert the same effects as insulin and, thus, the mechanisms of action of 10H2DA in energy metabolism need to be elucidated in more detail in future studies.
Royal jelly, which is a viscous yellowish substance secreted from the hypopharyngeal and mandibular glands of worker honeybees, consists of 3%-6% lipids, which, in turn, consist of 80%-85% fatty acids, 4%-10% phenols, 5%-6% waxes, 3%-4% steroids, and 0.4%-0.8% phospholipids (Yonekura, 2008) . Although 10H2DA possesses more than 30% fatty acids, it serves as a minor constituent in royal jelly (Lercker et al., 1981) . The concentration of 10H2DA used in the present study to demonstrate the suppression of AQP9 gene expression was 2-4 mM, which was converted into 372-744 µg/ml. 
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